 | • レポートコード：QYR9ST04129 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、がん幹細胞の世界市場について調査・分析し、がん幹細胞の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（細胞培養、細胞分離、細胞分析、分子分析、その他）、用途別（幹細胞ベースがん治療、標的CSC）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のがん幹細胞市場動向 ・主要企業別マーケットシェア ・がん幹細胞の種類別市場規模2014-2019 （細胞培養、細胞分離、細胞分析、分子分析、その他） ・がん幹細胞の用途別市場規模2014-2019 （幹細胞ベースがん治療、標的CSC） ・がん幹細胞の北米市場：主要企業・種類別/用途別市場規模 ・がん幹細胞のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・がん幹細胞の中国市場：主要企業・種類別/用途別市場規模 ・がん幹細胞の日本国内市場：主要企業・種類別/用途別市場規模 ・がん幹細胞の東南アジア市場：主要企業・種類別/用途別市場規模 ・がん幹細胞のインド市場：主要企業・種類別/用途別市場規模 ・がん幹細胞の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Thermo Fisher Scientific, Inc.、AbbVie, Inc.、Merck KGaA、Bionomics、Lonza、Stemline Therapeutics, Inc.、Miltenyi Biotec、PromoCell GmbH、MacroGenics, Inc.、OncoMed Pharmaceuticals, Inc.、Irvine Scientific、STEMCELL Technologies Inc.、Sino Biological Inc.、BIOTIME, Inc.） ・がん幹細胞の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.North America was the leading revenue contributor of the cancer stem cells market in 2016 due to presence of a substantial number of organizations engaged in conducting R&D activities related to stem cell therapy. There are several internationally recognized hospitals and medical institutes, such as Cancer Treatment Centers of America at Midwestern Regional Medical Center, which offer stem cell transplant therapies.
Asia Pacific is expected to be a promising region in the arena owing to presence of several organizations in the region that focus on R&D of stem cells. Moreover, funding agencies are providing grants to research communities to accelerate their scientific research on cancer stem cells in Asian countries.
In 2018, the global Cancer Stem Cell market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cancer Stem Cell status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Stem Cell development in United States, Europe and China.
The key players covered in this study
Thermo Fisher Scientific, Inc.
AbbVie, Inc.
Merck KGaA
Bionomics
Lonza
Stemline Therapeutics, Inc.
Miltenyi Biotec
PromoCell GmbH
MacroGenics, Inc.
OncoMed Pharmaceuticals, Inc.
Irvine Scientific
STEMCELL Technologies Inc.
Sino Biological Inc.
BIOTIME, Inc.
Market segment by Type, the product can be split into
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others
Market segment by Application, split into
Stem Cell Based Cancer Therapy
Targeted CSCs
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cancer Stem Cell status, future forecast, growth opportunity, key market and key players.
To present the Cancer Stem Cell development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cancer Stem Cell are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Stem Cell Market Size Growth Rate by Type (2014-2025)
1.4.2 Cell Culturing
1.4.3 Cell Separation
1.4.4 Cell Analysis
1.4.5 Molecular Analysis
1.4.6 Others
1.5 Market by Application
1.5.1 Global Cancer Stem Cell Market Share by Application (2014-2025)
1.5.2 Stem Cell Based Cancer Therapy
1.5.3 Targeted CSCs
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cancer Stem Cell Market Size
2.2 Cancer Stem Cell Growth Trends by Regions
2.2.1 Cancer Stem Cell Market Size by Regions (2014-2025)
2.2.2 Cancer Stem Cell Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Cancer Stem Cell Market Size by Manufacturers
3.1.1 Global Cancer Stem Cell Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Stem Cell Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Stem Cell Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Stem Cell Key Players Head office and Area Served
3.3 Key Players Cancer Stem Cell Product/Solution/Service
3.4 Date of Enter into Cancer Stem Cell Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cancer Stem Cell Market Size by Type (2014-2019)
4.2 Global Cancer Stem Cell Market Size by Application (2014-2019)
5 United States
5.1 United States Cancer Stem Cell Market Size (2014-2019)
5.2 Cancer Stem Cell Key Players in United States
5.3 United States Cancer Stem Cell Market Size by Type
5.4 United States Cancer Stem Cell Market Size by Application
6 Europe
6.1 Europe Cancer Stem Cell Market Size (2014-2019)
6.2 Cancer Stem Cell Key Players in Europe
6.3 Europe Cancer Stem Cell Market Size by Type
6.4 Europe Cancer Stem Cell Market Size by Application
7 China
7.1 China Cancer Stem Cell Market Size (2014-2019)
7.2 Cancer Stem Cell Key Players in China
7.3 China Cancer Stem Cell Market Size by Type
7.4 China Cancer Stem Cell Market Size by Application
8 Japan
8.1 Japan Cancer Stem Cell Market Size (2014-2019)
8.2 Cancer Stem Cell Key Players in Japan
8.3 Japan Cancer Stem Cell Market Size by Type
8.4 Japan Cancer Stem Cell Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cancer Stem Cell Market Size (2014-2019)
9.2 Cancer Stem Cell Key Players in Southeast Asia
9.3 Southeast Asia Cancer Stem Cell Market Size by Type
9.4 Southeast Asia Cancer Stem Cell Market Size by Application
10 India
10.1 India Cancer Stem Cell Market Size (2014-2019)
10.2 Cancer Stem Cell Key Players in India
10.3 India Cancer Stem Cell Market Size by Type
10.4 India Cancer Stem Cell Market Size by Application
11 Central & South America
11.1 Central & South America Cancer Stem Cell Market Size (2014-2019)
11.2 Cancer Stem Cell Key Players in Central & South America
11.3 Central & South America Cancer Stem Cell Market Size by Type
11.4 Central & South America Cancer Stem Cell Market Size by Application
12 International Players Profiles
12.1 Thermo Fisher Scientific, Inc.
12.1.1 Thermo Fisher Scientific, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Stem Cell Introduction
12.1.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2014-2019)
12.1.5 Thermo Fisher Scientific, Inc. Recent Development
12.2 AbbVie, Inc.
12.2.1 AbbVie, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Stem Cell Introduction
12.2.4 AbbVie, Inc. Revenue in Cancer Stem Cell Business (2014-2019)
12.2.5 AbbVie, Inc. Recent Development
12.3 Merck KGaA
12.3.1 Merck KGaA Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Stem Cell Introduction
12.3.4 Merck KGaA Revenue in Cancer Stem Cell Business (2014-2019)
12.3.5 Merck KGaA Recent Development
12.4 Bionomics
12.4.1 Bionomics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Stem Cell Introduction
12.4.4 Bionomics Revenue in Cancer Stem Cell Business (2014-2019)
12.4.5 Bionomics Recent Development
12.5 Lonza
12.5.1 Lonza Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Stem Cell Introduction
12.5.4 Lonza Revenue in Cancer Stem Cell Business (2014-2019)
12.5.5 Lonza Recent Development
12.6 Stemline Therapeutics, Inc.
12.6.1 Stemline Therapeutics, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Stem Cell Introduction
12.6.4 Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2014-2019)
12.6.5 Stemline Therapeutics, Inc. Recent Development
12.7 Miltenyi Biotec
12.7.1 Miltenyi Biotec Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Stem Cell Introduction
12.7.4 Miltenyi Biotec Revenue in Cancer Stem Cell Business (2014-2019)
12.7.5 Miltenyi Biotec Recent Development
12.8 PromoCell GmbH
12.8.1 PromoCell GmbH Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Stem Cell Introduction
12.8.4 PromoCell GmbH Revenue in Cancer Stem Cell Business (2014-2019)
12.8.5 PromoCell GmbH Recent Development
12.9 MacroGenics, Inc.
12.9.1 MacroGenics, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Stem Cell Introduction
12.9.4 MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2014-2019)
12.9.5 MacroGenics, Inc. Recent Development
12.10 OncoMed Pharmaceuticals, Inc.
12.10.1 OncoMed Pharmaceuticals, Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Stem Cell Introduction
12.10.4 OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2014-2019)
12.10.5 OncoMed Pharmaceuticals, Inc. Recent Development
12.11 Irvine Scientific
12.12 STEMCELL Technologies Inc.
12.13 Sino Biological Inc.
12.14 BIOTIME, Inc.
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Cancer Stem Cell Key Market Segments
Table Key Players Cancer Stem Cell Covered
Table Global Cancer Stem Cell Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Cancer Stem Cell Market Size Market Share by Type 2014-2025
Figure Cell Culturing Figures
Table Key Players of Cell Culturing
Figure Cell Separation Figures
Table Key Players of Cell Separation
Figure Cell Analysis Figures
Table Key Players of Cell Analysis
Figure Molecular Analysis Figures
Table Key Players of Molecular Analysis
Figure Others Figures
Table Key Players of Others
Table Global Cancer Stem Cell Market Size Growth by Application 2014-2025 (Million US$)
Figure Stem Cell Based Cancer Therapy Case Studies
Figure Targeted CSCs Case Studies
Figure Cancer Stem Cell Report Years Considered
Table Global Cancer Stem Cell Market Size 2014-2025 (Million US$)
Figure Global Cancer Stem Cell Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cancer Stem Cell Market Size by Regions 2014-2025 (Million US$)
Table Global Cancer Stem Cell Market Size by Regions 2014-2019 (Million US$)
Table Global Cancer Stem Cell Market Share by Regions 2014-2019
Figure Global Cancer Stem Cell Market Share by Regions 2014-2019
Figure Global Cancer Stem Cell Market Share by Regions 2019
Table Market Top Trends
Table Global Cancer Stem Cell Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Cancer Stem Cell Market Share by Manufacturers (2014-2019)
Figure Global Cancer Stem Cell Market Share by Manufacturers in 2018
Table Global Cancer Stem Cell Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cancer Stem Cell Product/Solution/Service
Table Date of Enter into Cancer Stem Cell Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cancer Stem Cell Market Size by Type (2014-2019) (Million US$)
Table Global Cancer Stem Cell Market Size Share by Type (2014-2019)
Figure Global Cancer Stem Cell Market Size Market Share by Type (2014-2019)
Table Global Cancer Stem Cell Market Size by Application (2014-2019) (Million US$)
Table Global Cancer Stem Cell Market Size Share by Application (2014-2019)
Figure Global Cancer Stem Cell Market Size Market Share by Application (2014-2019)
Figure Global Cancer Stem Cell Revenue Market Share by Application in 2018
Figure United States Cancer Stem Cell Market Size 2014-2019 (Million US$)
Table United States Key Players Cancer Stem Cell Revenue (2018-2019) (Million US$)
Table United States Key Players Cancer Stem Cell Market Share (2018-2019)
Table United States Cancer Stem Cell Market Size by Type (2014-2019) (Million US$)
Table United States Cancer Stem Cell Market Share by Type (2014-2019)
Table United States Cancer Stem Cell Market Size by Application (2014-2019) (Million US$)
Table United States Cancer Stem Cell Market Share by Application (2014-2019)
Figure Europe Cancer Stem Cell Market Size 2014-2019 (Million US$)
Table Europe Key Players Cancer Stem Cell Revenue (2018-2019) (Million US$)
Table Europe Key Players Cancer Stem Cell Market Share (2018-2019)
Table Europe Cancer Stem Cell Market Size by Type (2014-2019) (Million US$)
Table Europe Cancer Stem Cell Market Share by Type (2014-2019)
Table Europe Cancer Stem Cell Market Size by Application (2014-2019) (Million US$)
Table Europe Cancer Stem Cell Market Share by Application (2014-2019)
Figure China Cancer Stem Cell Market Size 2014-2019 (Million US$)
Table China Key Players Cancer Stem Cell Revenue (2018-2019) (Million US$)
Table China Key Players Cancer Stem Cell Market Share (2018-2019)
Table China Cancer Stem Cell Market Size by Type (2014-20189) (Million US$)
Table China Cancer Stem Cell Market Share by Type (2014-2019)
Table China Cancer Stem Cell Market Size by Application (2014-2019) (Million US$)
Table China Cancer Stem Cell Market Share by Application (2014-2019)
Figure Japan Cancer Stem Cell Market Size 2014-2019 (Million US$)
Table Japan Key Players Cancer Stem Cell Revenue (2018-2019) (Million US$)
Table Japan Key Players Cancer Stem Cell Market Share (2018-2019)
Table Japan Cancer Stem Cell Market Size by Type (2014-2019) (Million US$)
Table Japan Cancer Stem Cell Market Share by Type (2014-2019)
Table Japan Cancer Stem Cell Market Size by Application (2014-2019) (Million US$)
Table Japan Cancer Stem Cell Market Share by Application (2014-2019)
Figure Southeast Asia Cancer Stem Cell Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cancer Stem Cell Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cancer Stem Cell Market Share (2018-2019)
Table Southeast Asia Cancer Stem Cell Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cancer Stem Cell Market Share by Type (2014-2019)
Table Southeast Asia Cancer Stem Cell Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cancer Stem Cell Market Share by Application (2014-2019)
Figure India Cancer Stem Cell Market Size 2014-2019 (Million US$)
Table India Key Players Cancer Stem Cell Revenue (2018-2019) (Million US$)
Table India Key Players Cancer Stem Cell Market Share (2018-2019)
Table India Cancer Stem Cell Market Size by Type (2014-2019) (Million US$)
Table India Cancer Stem Cell Market Share by Type (2014-2019)
Table India Cancer Stem Cell Market Size by Application (2014-2019) (Million US$)
Table India Cancer Stem Cell Market Share by Application (2014-2019)
Figure Central & South America Cancer Stem Cell Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cancer Stem Cell Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cancer Stem Cell Market Share (2018-2019)
Table Central & South America Cancer Stem Cell Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cancer Stem Cell Market Share by Type (2014-2019)
Table Central & South America Cancer Stem Cell Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cancer Stem Cell Market Share by Application (2014-2019)
Table Thermo Fisher Scientific, Inc. Company Details
Table Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2014-2019) (Million US$)
Figure Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2014-2019)
Table Thermo Fisher Scientific, Inc. Recent Development
Table AbbVie, Inc. Company Details
Table AbbVie, Inc. Revenue in Cancer Stem Cell Business (2014-2019)(Million US$)
Figure AbbVie, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2014-2019)
Table AbbVie, Inc. Recent Development
Table Merck KGaA Company Details
Table Merck KGaA Revenue in Cancer Stem Cell Business (2014-2019)(Million US$)
Figure Merck KGaA Revenue Growth Rate in Cancer Stem Cell Business (2014-2019)
Table Merck KGaA Recent Development
Table Bionomics Company Details
Table Bionomics Revenue in Cancer Stem Cell Business (2014-2019)(Million US$)
Figure Bionomics Revenue Growth Rate in Cancer Stem Cell Business (2014-2019)
Table Bionomics Recent Development
Table Lonza Company Details
Table Lonza Revenue in Cancer Stem Cell Business (2014-2019)(Million US$)
Figure Lonza Revenue Growth Rate in Cancer Stem Cell Business (2014-2019)
Table Lonza Recent Development
Table Stemline Therapeutics, Inc. Company Details
Table Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2014-2019)(Million US$)
Figure Stemline Therapeutics, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2014-2019)
Table Stemline Therapeutics, Inc. Recent Development
Table Miltenyi Biotec Company Details
Table Miltenyi Biotec Revenue in Cancer Stem Cell Business (2014-2019)(Million US$)
Figure Miltenyi Biotec Revenue Growth Rate in Cancer Stem Cell Business (2014-2019)
Table Miltenyi Biotec Recent Development
Table PromoCell GmbH Company Details
Table PromoCell GmbH Revenue in Cancer Stem Cell Business (2014-2019)(Million US$)
Figure PromoCell GmbH Revenue Growth Rate in Cancer Stem Cell Business (2014-2019)
Table PromoCell GmbH Recent Development
Table MacroGenics, Inc. Company Details
Table MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2014-2019)(Million US$)
Figure MacroGenics, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2014-2019)
Table MacroGenics, Inc. Recent Development
Table OncoMed Pharmaceuticals, Inc. Company Details
Table OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2014-2019)(Million US$)
Figure OncoMed Pharmaceuticals, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2014-2019)
Table OncoMed Pharmaceuticals, Inc. Recent Development
Table Irvine Scientific Company Details
Table STEMCELL Technologies Inc. Company Details
Table Sino Biological Inc. Company Details
Table BIOTIME, Inc. Company Details
Table Global Cancer Stem Cell Market Size by Regions (Million US$) 2019-2025
Figure Global Cancer Stem Cell Market Size Share by Regions (2019-2025)
Figure Global Cancer Stem Cell Market Size Share by Regions in 2025
Figure United States Cancer Stem Cell Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cancer Stem Cell Market Size Forecast (2019-2025)(Million USD)
Figure China Cancer Stem Cell Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cancer Stem Cell Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cancer Stem Cell Market Size Forecast (2019-2025)(Million USD)
Figure India Cancer Stem Cell Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cancer Stem Cell Market Size Forecast (2019-2025)(Million USD)
Table Global Cancer Stem Cell Market Size by Product (2019-2025) (Million US$)
Figure Global Cancer Stem Cell Market Size by Product (2019-2025)
Figure Global Cancer Stem Cell Market Size by Product in 2025
Table Global Cancer Stem Cell Market Size by Application (2019-2025) (Million US$)
Figure Global Cancer Stem Cell Market Size by Application (2019-2025)
Figure Global Cancer Stem Cell Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
変形性関節症向け幹細胞療法の世界市場：市場規模・現状・予測 Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe.The expected growth is becau…- 多発性硬化症向け幹細胞療法の世界市場：市場規模・現状・予測 Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
- 犬幹細胞療法の世界市場：市場規模・現状・予測 The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…
- 糖尿病及び関連疾患向け幹細胞療法の世界市場：市場規模・現状・予測 Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2).NSI-566 is the stem cell therap…
- 糖尿病及び関連疾患向け幹細胞療法の世界市場：市場規模・現状・予測 Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2).NSI-566 is the stem cell therap…